CLINICAL_TRIALS
trial_result
· 2023-03-10
Clinical Trial Update: A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms [Phase 2]
Summary
Phase 2 trial of BAY3427080 (NT-814) in moderate to severe post-menopausal vasomotor symptoms completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Menopause, Hot Flashes | Phase 2 | Status: COMPLETED | Results posted: 2023-03-10